Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
Abstract The advent of immunotherapy has marked a new era in cancer treatment, offering significant clinical benefits. Cell membrane as drug delivery materials has played a crucial role in enhancing cancer therapy because of their inherent biocompatibility and negligible immunogenicity. Different ce...
Main Authors: | Qinzhen Cheng, Yong Kang, Bin Yao, Jinrui Dong, Yalan Zhu, Yiling He, Xiaoyuan Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202302131 |
Similar Items
-
Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment
by: Jiang Y, et al.
Published: (2024-03-01) -
Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation
by: Adil Ali Sayyed, et al.
Published: (2023-10-01) -
Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications
by: Meng Sun, et al.
Published: (2023-11-01) -
Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes
by: Adrian Villalba, et al.
Published: (2020-01-01) -
Stem Cell-Engineered Nanovesicles Exert Proangiogenic and Neuroprotective Effects
by: Han Young Kim, et al.
Published: (2021-02-01)